Caplin Point Laboratories share news, announcements and annual reports
NSE: CAPLIPOINTBSE: 524742Pharmaceuticals & BiotechnologySmall Cap
Caplin Point Laboratories Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 1995 on BSE, Jun 2014 on NSE
Last close ₹2,376.10up ₹13.30 (0.56%)BSE ₹2,373.60
Share price at the NSE close on 29 Oct 2026. Previous close ₹2,362.80.
29 Oct: open ₹2,356.20, high ₹2,409.90, low ₹2,344.10
52-week range of traded prices to 29 Oct 2026
₹1,500.30Low, 30 Mar 2026₹2,990.00High, 24 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹18,061 Cr453rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 27.15
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.04
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.34%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 85,557
Caplin Point Laboratories share news and announcements
492 announcements, routine notices left out, newest first. Page 6 of 10.
Apr 2021
Feb 2021
11 Feb · Legal
Exchange has sought clarification from Caplin Point Laboratories Limited with respect to announcement dated 05-Feb-2021, regarding Resignation of Mr VINOD KUMAR S as Company Secretary of the company w.e.f. February 05, 2021.On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment)The response of the Company is awaited.4 Feb · Results
2 Feb · Analysts
Jan 2021
29 Jan · Board meeting
Dec 2020
28 Dec · Analysts
21 Dec · Analysts
Nov 2020
20 Nov · Analysts
10 Nov · Analysts
5 Nov · Results
Oct 2020
30 Oct · Analysts
29 Oct · Board meeting
9 Oct · Analysts
Sep 2020
30 Sep · Analysts
30 Sep · Updates
29 Sep · Meeting
24 Sep · Analysts
17 Sep · Analysts
11 Sep · Analysts
4 Sep · Analysts
1 Sep · Analysts
Aug 2020
27 Aug · Analysts
21 Aug · Analysts
17 Aug · Analysts
10 Aug · Results
3 Aug · Analysts
3 Aug · Board meeting
Jul 2020
2 Jul · Analysts
Jun 2020
18 Jun · Results
10 Jun · Updates
May 2020
Apr 2020